We investigated the effects of the exposure of ABT-737, an apoptosis- and thrombocytopenia-inducing drug, on the expression of FADD and DJ-1 as well as on the caspase-8 activity in human platelets. This evidence concerns the gene PARK7 and Thrombocytopenia.